| Review Article Online Published: 30 Nov 2025 | ||||||||||||
IJMDC. 2025; 9(11): 2833-2841 Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review Hyder Osman Mirghani, Wejdan Ahmed Aldawsari, Abdulmalik Khaled Albalawi, Khalid Ahmed Aldawsari, Ryan Mohammed M. Alqahtani, Asiri Abdullah Hassan A, Hamad Saud Sultan, Bandar Mohammed F Alanazi, Yazeed Mohammed A Alanazi, Hanan Saud O Almarwani, Waleed Thaqal S Alotaibi, Alenzi Saleh Abdulrhman S, Abdulkarim Omar Abdullah Althobaiti, Saleh Mohammed Suliman Alatawi.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Mirghani HO, Aldawsari WA, Albalawi AK, Aldawsari KA, Alqahtani RMM, A AAH, Sultan HS, Alanazi BMF, Alanazi YMA, Almarwani HSO, Alotaibi WTS, S ASA, Althobaiti AOA, Alatawi SMS. Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. IJMDC. 2025; 9(11): 2833-2841. doi:10.24911/IJMDC.51-1758187996 Web Style Mirghani HO, Aldawsari WA, Albalawi AK, Aldawsari KA, Alqahtani RMM, A AAH, Sultan HS, Alanazi BMF, Alanazi YMA, Almarwani HSO, Alotaibi WTS, S ASA, Althobaiti AOA, Alatawi SMS. Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. https://www.ijmdc.com/?mno=284804 [Access: June 27, 2026]. doi:10.24911/IJMDC.51-1758187996 AMA (American Medical Association) Style Mirghani HO, Aldawsari WA, Albalawi AK, Aldawsari KA, Alqahtani RMM, A AAH, Sultan HS, Alanazi BMF, Alanazi YMA, Almarwani HSO, Alotaibi WTS, S ASA, Althobaiti AOA, Alatawi SMS. Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. IJMDC. 2025; 9(11): 2833-2841. doi:10.24911/IJMDC.51-1758187996 Vancouver/ICMJE Style Mirghani HO, Aldawsari WA, Albalawi AK, Aldawsari KA, Alqahtani RMM, A AAH, Sultan HS, Alanazi BMF, Alanazi YMA, Almarwani HSO, Alotaibi WTS, S ASA, Althobaiti AOA, Alatawi SMS. Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. IJMDC. (2025), [cited June 27, 2026]; 9(11): 2833-2841. doi:10.24911/IJMDC.51-1758187996 Harvard Style Mirghani, H. O., Aldawsari, . W. A., Albalawi, . A. K., Aldawsari, . K. A., Alqahtani, . R. M. M., A, . A. A. H., Sultan, . H. S., Alanazi, . B. M. F., Alanazi, . Y. M. A., Almarwani, . H. S. O., Alotaibi, . W. T. S., S, . A. S. A., Althobaiti, . A. O. A. & Alatawi, . S. M. S. (2025) Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. IJMDC, 9 (11), 2833-2841. doi:10.24911/IJMDC.51-1758187996 Turabian Style Mirghani, Hyder Osman, Wejdan Ahmed Aldawsari, Abdulmalik Khaled Albalawi, Khalid Ahmed Aldawsari, Ryan Mohammed M. Alqahtani, Asiri Abdullah Hassan A, Hamad Saud Sultan, Bandar Mohammed F Alanazi, Yazeed Mohammed A Alanazi, Hanan Saud O Almarwani, Waleed Thaqal S Alotaibi, Alenzi Saleh Abdulrhman S, Abdulkarim Omar Abdullah Althobaiti, and Saleh Mohammed Suliman Alatawi. 2025. Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. International Journal of Medicine in Developing Countries, 9 (11), 2833-2841. doi:10.24911/IJMDC.51-1758187996 Chicago Style Mirghani, Hyder Osman, Wejdan Ahmed Aldawsari, Abdulmalik Khaled Albalawi, Khalid Ahmed Aldawsari, Ryan Mohammed M. Alqahtani, Asiri Abdullah Hassan A, Hamad Saud Sultan, Bandar Mohammed F Alanazi, Yazeed Mohammed A Alanazi, Hanan Saud O Almarwani, Waleed Thaqal S Alotaibi, Alenzi Saleh Abdulrhman S, Abdulkarim Omar Abdullah Althobaiti, and Saleh Mohammed Suliman Alatawi. "Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review." International Journal of Medicine in Developing Countries 9 (2025), 2833-2841. doi:10.24911/IJMDC.51-1758187996 MLA (The Modern Language Association) Style Mirghani, Hyder Osman, Wejdan Ahmed Aldawsari, Abdulmalik Khaled Albalawi, Khalid Ahmed Aldawsari, Ryan Mohammed M. Alqahtani, Asiri Abdullah Hassan A, Hamad Saud Sultan, Bandar Mohammed F Alanazi, Yazeed Mohammed A Alanazi, Hanan Saud O Almarwani, Waleed Thaqal S Alotaibi, Alenzi Saleh Abdulrhman S, Abdulkarim Omar Abdullah Althobaiti, and Saleh Mohammed Suliman Alatawi. "Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review." International Journal of Medicine in Developing Countries 9.11 (2025), 2833-2841. Print. doi:10.24911/IJMDC.51-1758187996 APA (American Psychological Association) Style Mirghani, H. O., Aldawsari, . W. A., Albalawi, . A. K., Aldawsari, . K. A., Alqahtani, . R. M. M., A, . A. A. H., Sultan, . H. S., Alanazi, . B. M. F., Alanazi, . Y. M. A., Almarwani, . H. S. O., Alotaibi, . W. T. S., S, . A. S. A., Althobaiti, . A. O. A. & Alatawi, . S. M. S. (2025) Efficacy and safety of empagliflozin to reduce atrial fibrillation episodes: systematic review. International Journal of Medicine in Developing Countries, 9 (11), 2833-2841. doi:10.24911/IJMDC.51-1758187996 |